Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma
Amgen
Amgen
Amsterdam UMC, location VUmc
Johnson & Johnson Private Limited
Peking Union Medical College Hospital
CASI Pharmaceuticals (China) Co., Ltd.
Centre Hospitalier Universitaire de Nice
Odense University Hospital
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Novartis
PETHEMA Foundation
Columbia University
Dana-Farber Cancer Institute
University of Maryland, Baltimore
Medtronic Spinal and Biologics
Johnson & Johnson Taiwan Ltd
Swedish Orphan Biovitrum
Novartis
Novartis
Millennium Pharmaceuticals, Inc.